Clinical trial
A Phase 2, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
NCT03838133 is registered in ClinicalTrials.gov with Taiwan Liposome Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
- Lead sponsor
- Taiwan Liposome Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 5, 2019
- Completion date
- March 31, 2020
- Enrollment
- 150 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.